|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0024109,
umls-concept:C0392756,
umls-concept:C0599894,
umls-concept:C0700624,
umls-concept:C0871261,
umls-concept:C1155065,
umls-concept:C1332822,
umls-concept:C1527148,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-8-1
|
|
pubmed:abstractText |
Asthma is a chronic airway inflammatory disease that is associated with a large influx of inflammatory cells. Several chemokines and chemokine receptors play critical roles in the development of allergic airway inflammation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1534-4436
|
|
pubmed:author |
pubmed-author:CoxMaryAnn LML,
pubmed-author:FineJay SJS,
pubmed-author:GelfandErwin WEW,
pubmed-author:JenhChung-HerCH,
pubmed-author:LawPP,
pubmed-author:LundelDanielD,
pubmed-author:ManfraDenise JDJ,
pubmed-author:OhnishiHiroshiH,
pubmed-author:RosenblumStuartS,
pubmed-author:ShinYoo SeobYS,
pubmed-author:ShiraishiYoshikiY,
pubmed-author:TakedaKatsuyukiK
|
|
pubmed:copyrightInfo |
Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
145-53
|
|
pubmed:meshHeading |
pubmed-meshheading:21802023-Animals,
pubmed-meshheading:21802023-Asthma,
pubmed-meshheading:21802023-Cell Movement,
pubmed-meshheading:21802023-Disease Models, Animal,
pubmed-meshheading:21802023-Disease Progression,
pubmed-meshheading:21802023-Female,
pubmed-meshheading:21802023-Humans,
pubmed-meshheading:21802023-Immunotherapy,
pubmed-meshheading:21802023-Lymphocyte Activation,
pubmed-meshheading:21802023-Mice,
pubmed-meshheading:21802023-Mice, Inbred BALB C,
pubmed-meshheading:21802023-Mice, Transgenic,
pubmed-meshheading:21802023-Molecular Targeted Therapy,
pubmed-meshheading:21802023-Pneumonia,
pubmed-meshheading:21802023-Receptors, CXCR3,
pubmed-meshheading:21802023-Respiratory Function Tests,
pubmed-meshheading:21802023-Th2 Cells
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Targeting CXCR3 reduces ligand-induced T-cell activation but not development of lung allergic responses.
|
|
pubmed:affiliation |
Division of Cell Biology, Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
